Regulation and Mechanism of New Compound Functional Ingredients in Infants
Study Details
Study Description
Brief Summary
A prospective, multicentre, randomized, double-blind, parallel control study was conducted to analyze the changes in growth, intestinal flora, and immune function of infants with different feeding patterns from postnatal to 1 year of age.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Breast milk is the most beneficial and safe natural food for the growth and development of infants, but some mothers cannot complete breast feeding.For infants who cannot be breastfed, how to improve the composition of formula milk powder and improve the growth and development of infants is an important issue to be solved urgently in this field.It has been found that new compound functional ingredients oligosaccharides and sialic acid may be beneficial to the healthy growth and development of infants and young children, but the specific mechanism and significance are still unclear due to the lack of systematic research.Known as the "second Brain", the gut is connected to the Brain via the brain-gut-axis.Intestinal microecological status can significantly affect the development of infant nervous system and immune system, and then affect the occurrence of related diseases in adulthood.Oligosaccharides and sialic acid may affect the structure of intestinal microecology, protect the immune function of infants and promote the healthy development of infants.This project is based on the previous studies, using multicenter, prospective, randomized, double-blind, parallel-group trial, discussion of oligosaccharides and sialic acid in infants and young children the intestinal micro ecology and the regulation of immune function and the role mechanism, revealing the oligosaccharides and sialic acid in infants and young children the role of immediate and long-term growth, and the significance of these new type of composite function is added to the dairy ingredients, to research and development more accord with our country new dairy products provide theoretical basis for the healthy growth of infants and young children.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Breastfeeding group The mother can breastfeed exclusively until the infants is at least 4 months old, after which complementary foods are added scientifically according to the baby's condition. |
|
| Formula group containing new compound functional ingredients Only use formula milk powder containing oligosaccharides, sialic acid and other ingredients feed the infants for at least 4 months, and then complementary food is added scientifically according to the infant's condition. |
Dietary Supplement: The infants who drank milk powder were given a dietary intervention four months before
The infants who eat milk powder were randomly divided into two groups: group containing new compound functional ingredients and group without new compound functional ingredients
|
| Formula group without new compound functional ingredients Only use formula milk powder without oligosaccharides, sialic acid and other ingredients feed the infants for at least 4 months, and then complementary food is added scientifically according to the infant's condition. |
Dietary Supplement: The infants who drank milk powder were given a dietary intervention four months before
The infants who eat milk powder were randomly divided into two groups: group containing new compound functional ingredients and group without new compound functional ingredients
|
Outcome Measures
Primary Outcome Measures
- Growth and development indexes [12 months]
Baby body length, weight, head circumference gain
- Growth and development indexes [12 months]
Baby body weight gain
- Growth and development indexes [12 months]
Baby body head circumference gain
- Neurodevelopmental level [4 months]
The Peabody scale was used to assess the level of neural development of infants at 4 months and 6 months
- Neurodevelopmental level [6 months]
The Peabody scale was used to assess the level of neural development of infants at 6 months
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy infants;
-
Full-term (gestational age ≥37 weeks);
-
Birth weight 2500-4500g;
-
Mothers have no history of diabetes, hypertension, heart disease, and other diseases during pregnancy;
-
The guardian signed informed consent and voluntarily enrolled into the group and promised to complete systematic follow-up.
Exclusion Criteria:
-
Hospitalization with cognitive impairment or deformity ≥2 days
-
History of birth asphyxia (Apgar score < 3)
-
Severe allergy to milk and serious medical conditions such as intracranial hemorrhage, chronic diarrhea, necrotizing colitis, or acute infection
-
The guardian refused to enroll or could not complete the system follow-up.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Peking University People's Hospital | Beijing | Beijing | China | 100191 |
| 2 | Peking University Third Hospital | Beijing | Beijing | China | 100191 |
| 3 | Peking University First Hospital | Beijing | China | 100191 |
Sponsors and Collaborators
- Peking University Third Hospital
- Peking University First Hospital
- Peking University People's Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- S170003